Please login to the form below

Not currently logged in
Email:
Password:

genetic research

This page shows the latest genetic research news and features for those working in and with pharma, biotech and healthcare.

Gyroscope advances gene therapy platform, merges with Orbit

Gyroscope advances gene therapy platform, merges with Orbit

organ, and decades of research into the genetic basis of numerous eye conditions.

Latest news

  • UK Biobank generates “largest open access resource of exome data” UK Biobank generates “largest open access resource of exome data”

    to fruition, as new genetic data becomes available to the global health research community. ... Both companies have a vested interest in the area. GSK has committed a £40m investment to similar genetic research initiatives to more accurately streamline

  • GSK and Sanofi join Finland's 500,000 genomics study GSK and Sanofi join Finland's 500,000 genomics study

    First launched in 2017, the project aims to contribute to genetic research by ultimately identifying new therapeutic targets and diagnostics for treating numerous diseases. ... FinnGen offers an exciting collaborative opportunity to study genetic impacts

  • UK site a casualty as Pfizer reduces pain R&D UK site a casualty as Pfizer reduces pain R&D

    out in a deal that combined it with US contract research organisation (CRO) XRPro Sciences. ... The company pointed out that it has opened two research facilities in London - the Genetic Medicines Institute (GMI) and the Rare Disease Consortium (RDC) -

  • Teva takes controlling stake in genomics specialist Teva takes controlling stake in genomics specialist

    Cambridge, Massachusetts-based Immuneering specialises in the analysis of genetic, genomic and proteomic data that according to Teva's R&D chief Michael Hayden can "cut through, link and interpret enormous ... Immuneering has been working with Teva for

  • Pfizer launches lupus study with 23andMe Pfizer launches lupus study with 23andMe

    Research on human genetics has enormous potential to deliver information that can help improve lupus treatment. ... Signed in January, this added to the partners' existing research agreement in ulcerative colitis and Crohn's disease.

More from news
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    According to Dr Weir, if a patient is taught about the basis of his disease, he is more willing to collaborate on the research side, providing blood or genetic testing at ... on transparency as part of his role on EFPIA's research directors group.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Horizon Discovery appoints executive director Horizon Discovery appoints executive director

    David Smoller is chief business officer at the genomics firm. UK-based genetic research company Horizon Discovery has named Dr David Smoller as an executive director of the board. ... 1996. Horizon is a UK-based biotech focused on genomics research and

  • Redx names former Bayer exec as chairman Redx names former Bayer exec as chairman

    He will now help guide Redx as it advances its research efforts into infectious diseases and cancer. ... Redx is also working with AZ and this week announced the two companies had signed a collaboration to research the genetic drivers of tumour growth.

  • Horizon appoints board chair Horizon appoints board chair

    The UK-based genetic research firm will look to benefit from Dr Gilham's thirty years of industry experience, which includes his role as CEO of in vitro diagnostics company ... These growth prospects include a partnership with AstraZeneca to research

  • Melinta names chief medical officer Melinta names chief medical officer

    At Pharmacia, she worked on the anti-infective Zyvox (linezolid). Her most recent role prior to joining Melinta was as VP, clinical research at Shire's human genetic therapies division.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics